Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.
www.marketwatch.com
#Abbott #paying #billion #Exact #Sciences #Cologuard #cancer #test
Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
